CTI BioPharma Corp. (CTIC) Declined -6.25% or -0.13 To Price $1.95 On Friday


CTI BioPharma Corp. (CTIC) declined -6.25% or -0.13 to $1.95. It is nearly 944909 shares traded, which is 100.03% compare to the average total volume 944614. The market cap of CTIC is $113.08 million. The year to date change is -29.21%. The 52 week price range is from $1.95 to $5.36. Price of CTIC have changed -8.37% during last week. It have changed -55.36% over last month, -48.77% over last 3 months, -37.35% over last 6 months and -38.10% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTIC is 3.92. It is 101.03% above current price. The 200-day Moving Averages for CTIC is 3.57. It is 83.08% above current price. The 52-week High is 5.36. It is 174.87% from the current price. The 52-week Low is 1.95. The stock hits 52-week low today.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CTIC is 3.25 on 2018-07-13. Short % to float is 5.50%. There are some statistics of CTIC. It is has market cap $113.08 million. The share outstanding is 57.99 million. The average volume is 944614. The percent of top 15 Institution holding is 68.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTIC is -73.18%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTIC is -43.67%.


Tags:

Share this post